FDA.reportPublic FDA data

deuruxolitinib 8 MG Oral Tablet

RxCUI
2716563
RxNorm name
deuruxolitinib 8 MG Oral Tablet
Display name
deuruxolitinib 8 MG Oral Tablet
Full name
deuruxolitinib 8 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:12

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a603f231-d09e-4bad-ad5e-b55f865da095deuruxolitinib 8 MG Oral Tablet [PSN] · deuruxolitinib 8 MG Oral Tablet [SCD]211These highlights do not include all the information needed to use LEQSELVI safely and effectively. See full prescribing information for LEQSELVI. LEQSELVI™ (deuruxolitinib) tablets, for oral use Initial U.S. Approval: 202420250717